Form 4 for SXTP 60 DEGREES PHARMACEUTICALS, INC.
Accepted 2024-11-21 00:00:00 ET · period of report 2024-11-19 · accession 0001213900-24-101110 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-11-21 | 2024-11-19+ | SXTP | DOW GEOFFREY S | Pres, CEO, Dir | P - Purchase | $0.9079 | +7,000 | 17.1K | +69% | +$6,355 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-19 | P | A | 2,500 | $0.9 | 16,129 | D | — | — | (F1) Adjusted for the Issuer's 12-for-1 reverse stock split effected on August 12, 2024. |
| 2 | Common | Common Stock | 2024-11-21 | P | A | 3,500 | $0.91 | 20,629 | D | — | — | (F1) Adjusted for the Issuer's 12-for-1 reverse stock split effected on August 12, 2024. |
| 3 | Common | Common Stock | 2024-11-20 | P | A | 1,000 | $0.92 | 17,129 | D | — | — | (F1) Adjusted for the Issuer's 12-for-1 reverse stock split effected on August 12, 2024. |